Connect with us

Hi, what are you looking for?

Jewish Business News


Senate Passes Bill Giving Congress Review of Iran Nuclear Deal

Legislation would prevent Obama from waiving sanctions on Iran for 30 days during review

The Senate side of the United States Capitol building in Washington,   DC (photo credit Wikipedia)


On Thursday, U.S. Senate passed a bill with overwhelming majority, giving sweeping powers to the Congress in the pending nuclear deal with Iran. The Senate approved the bill 98-to-1, granting Congress 30 days to review any final nuclear agreement with Iran and pass a resolution of disapproval. If Congress rejects the nuclear deal, it could curb President Obama’s ability to lift some of the sanctions against Iran.

The White House initially opposed the bill asking Senate Democrats to reject the bill, citing concerns that a legislative move at this stage could hamper the ongoing international with negotiations with Iran. The administration retreated from its tough stand after realising overwhelming support amongst Senate Democrats in favour of the legislation.

In case President Obama decides to push ahead despite congressional disapproval, he would only be able to lift sanctions imposed against Iranian Regime by the executive wing of the government, leaving sanctions drafted by the Congress untouched.

President Obama could use his executive powers to lift bulk of sanctions imposed against Tehran. This relief in conjunction with United Nation’s and European Union’s easing of sanctions, could allow a nuclear deal with Iran to go through.

An overwhelming approval of the bill by the Senate Democrats reveals Obama administration’s inability to make a convincing case within the Democratic establishment for a negotiated deal with Iran.


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.